As of March 2025 Immunome has a market cap of A$1.21 Billion. This makes Immunome the world's 5991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 4th, 2025 the market cap of Immunome was reported to be: